Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,604.50
Bid: 1,604.00
Ask: 1,604.50
Change: -5.50 (-0.34%)
Spread: 0.50 (0.031%)
Open: 1,611.50
High: 1,615.50
Low: 1,599.50
Prev. Close: 1,610.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Earnings, Trading Statements Calendar - Week Ahead

Thu, 23rd Apr 2015 15:08

UK Earnings, Trading Statements Calendar 
Friday, April 24 
AstraZenecaQ1 Results at 1200 BST
PearsonQ1 Interim Management Statement
RecordTrading Statement 
Phoenix Group HoldingsQ1 Interim Management Statement
SpectrisTradung Statement
Reckitt BenckiserQ1 Trading Statement 
Monday, April 27 
PlaytechInterim Management Statement
CentricaInterim Management Statement
Lok'nStore GroupHalf Year Results
RotorkInterim Management Statement
Polyus Gold InternationalTrading Statement 
LifeLine ScientificFull Year Results
Tuesday, April 28 
Allied MindsFull Year Results
Avocet MiningFull Year Results 
Synety GroupTrading Statement 
Henderson GroupInterim Management Statement
BPQ1 Results
SEGROQ1 Interim Management Statement
St James's PlaceQ1 Interim Management Statement
Xeros Technology GroupHalf Year Results
Gresham HouseFull Year Results
WhitbreadFull Year Results 
RexamInterim Management Statement
Standard CharteredQ1 Interim Management Statement at 0915 BST
Aseana Properties Full Year Results 
AB DyanamicsHalf Year Results
Wednesday, April 29 
AntofagastaQ1 Production Report
GlaxoSmithKlineQ1 Results
NextQ1 Interim Management Statement 
Home Retail GroupFull Year Results
TSB Banking GroupQ1 Interim Management Statement 
RedefineHalf Year Results
DevroInterim Management Statement
StagecoachTrading Statement 
British American TobaccoQ1 Interim Management Statement 
Development Securities Full Year Results
GreggsTrading Statement 
Standard LifeTrading Statement 
N BrownFull Year Results 
Weir GroupQ1 Interim Management Statement 
BarclaysQ1 Interim Management Statement 
London Stock ExchangeQ1 Interim Management Statement 
PetropavlovskFull Year Results
Thursday, April 30 
IAGQ1 Results
James Fisher & SonsInterim Management Statement
STV GroupInterim Management Statement
Howden JoineryInterim Management Statement
GloboFull Year Results
International Personal FinanceQ1 Interim Management Statement 
SynthomerInterim Management Statement
ShireQ1 Results
SagaFull Year Results
Harvey Nash Group Full Year Results
SchrodersQ1 Interim Management Statement 
Royal Dutch ShellQ1 Results
Goldenport HoldingsFull Year Results
Moneysupermarket.comTrading Statement 
Asia Resource MineralsQ1 Results
Kaz MineralsQ1 Interim Management Statement 
Superglass HoldingsHalf Year Results
Tullow OilInterim Management Statement
Go-AheadInterim Management Statement
Lancashire HoldingsQ1 Results
Royal Bank of ScotlandQ1 Results
Smith & NephewQ1 Results
BerendsenTrading Statement 
  
Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 19:02

Moderna says it hit its 2023 COVID vaccine sales goal

Jan 8 (Reuters) - Moderna on Monday said its 2023 COVID vaccine sales would be around $6.7 billion, coming in above the lower end of its full-year forecast, and reiterated its goal of returning to sales growth in 2025.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.